Bausch Health Mergers & Acquisitions

Bausch Health M&A Summary

Bausch Health has acquired 41 companies, including 2 in the last 5 years. A total of 13 acquisitions came from private equity firms. It has also divested 10 assets.

Bausch Health’s largest acquisition to date was in 2015, when it acquired Salix Pharmaceuticals for $14.5B. It’s largest disclosed sale occurred in 2017, when it sold Inova Pharmaceuticals Pte to Pacific Equity Partners for $930M. Bausch Health has acquired in 10 different US states, and 12 countries. The Company’s most targeted sectors include life science (62%) and consumer products (17%).

M&A Summary

  • M&A Total Activity46
    • M&A Buy Activity36
    • M&A Sell Activity10
  • Total Sectors Invested 4
  • Total Countries Invested 12
  • M&A Buy/Sell Connections 34

Bausch Health

Bausch Health Companies, Inc.

2150 St. Elzear Boulevard West,
Laval, Quebec H7L 4A8
Canada,
(514) 744-6792
www.bauschhealth.com

All (46) Buy (36) Sell (10)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-07-29 Durect · Life Science
Cupertino, California · www.durect.com

Durect is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Durect was founded in 1988 and is based in Cupertino, California.

Revenue (mlns) 2 USD
Advisors: Locust Walk Partners , Orrick
63
31.5x REVENUE
Add-on Acquisition

Bausch Health
Advisors: Centerview Partners , Sullivan & Cromwell

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.